Eculizumab para tratar el síndrome hemolítico urémico atípico

Autores
Categoría Resumen estructurado de revisiones sistemáticas
RevistaHTA Database
Año 2013
RECORD STATUS: This is a bibliographic record of an ongoing health technology assessment being undertaken by a member of INAHTA. Links to the published report and any other relevant documentation will be added when available. CITATION: Eculizumab for treating atypical haemolytic uraemic syndrome. Health Technology Assessment
Epistemonikos ID: 339c419dcb9f2576cc536bc00e15353f080fff59
First added on: Feb 06, 2015